Abstract: Intranasal iontophoretic administration of therapeutics such as Reduced Water (RW) or lubeluzole as a means of treating diseases of the CNS involving oxidative stress.

Abstract: Co-administration of an effective amount of autoantigen and UV light to mucosal associated lymphatic tissue (MALT) in a patient.

Abstract: A UV probe capable of providing a Th2 immune environment for the treatment of back pain.

Abstract: A method of treating Alzheimer's Disease in which intranasal red light devices are used to shine red light upon the brain structures.

Abstract: This invention relates to a graft for treating Parkinson's Disease, wherein, in one embodiment, the graft contains an effective amount of both a) adrenal chromaffin cells (ACCs), and b) olfactory ensheathing cells (OECs), and GDF-5.

Abstract: Bone marrow aspirate from which water and fat have been substantially removed.

Abstract: Heating the hypothalamus, preferably by ultrasound, to cause the release of ?MSH in the brain.

Abstract: A method of adding an effective amount of reactive oxygen species (ROS) to a mixture of macrophages to induce VEGF production by the macrophages. The induced macrophages are then added to a graft material.

Abstract: This invention relates to an implantable device that delivers an effective amounts of red light to the substantia nigra as a treatment for Parkinson's Disease (PD).

Abstract: A UV probe capable of providing a Th2 immune environment for the treatment of back pain.

Abstract: Active immunization and a formulation for treating or preventing osteolysis caused by Wear Particles, comprising: a) a Th2 -inducing adjuvant, and b) Wear Particles.

Abstract: Irradiating osteolytic regions with UVB light.

Abstract: An intracranial, light-emitting implant for providing therapy to a patient having Alzheimer's Disease.

Abstract: Administering to a patient Type I interferon or viable cells induced to produce Type I Interferon preferably into an inflamed joint, such an interverebral disc, for example, is disclosed.

Abstract: Administering a buffy coat and immunoglobulin into a disc to induce the production of interleukin receptor antagonist protein IRAP within the disc is disclosed.

Abstract: An enhanced adipose tissue containing native adipose tissue and a concentrated amount of an active agent derived from adipose tissue, wherein the enhanced adipose tissue is preferably injected into the intervertebral disc of a patient suffering from degenerative disc disease.

Abstract: Administering an effective amount of adiponectin into an osteolytic region.

Abstract: A hydrocephalus shunt has photocatalytic capabilities. The shunt is used to treat hydrocephalus by inserting into a human cranium a hydrocephalus shunt having a component having a surface. Thereafter, a reactive oxygen species is produced on the component surface. The component may be a catheter. The shunt may also include a light source.

Abstract: An implant comprises a photocatalytic layer on at least one surface. In some embodiments, the photocatalytic layer is a semiconductor oxide that is doped. According to some embodiments, the implant comprises a wave guide. According to some embodiments the implant comprises a light port. According to some embodiments, the implant comprises a reflective material on a surface of the waveguide. According to some embodiments the implant comprises a composite material comprising a first material that has a transmissivity when exposed to a predetermined wavelength of light and a second material that has photocatalytic activity when exposed to the predetermined wavelength of light. According to some embodiments the implant comprises a light source adapted to irradiate the photocatalytic surface.

Abstract: This invention relates to local administration of a bone-forming agent and at least one anti-resorptive agent to treat osteoporosis and related disorders.